India Globalization Capital Inc. (IGC) Short Interest Update

India Globalization Capital Inc. (NYSEAMERICAN:IGC) saw a large decline in short interest in April. As of April 13th, there was short interest totalling 320,109 shares, a decline of 10.2% from the March 30th total of 356,431 shares. Based on an average daily trading volume, of 464,510 shares, the days-to-cover ratio is currently 0.7 days. Currently, 1.3% of the shares of the stock are short sold.

IGC stock opened at $0.57 on Thursday. India Globalization Capital has a 52 week low of $0.30 and a 52 week high of $1.63.

India Globalization Capital (NYSEAMERICAN:IGC) last released its quarterly earnings results on Tuesday, February 20th. The construction company reported ($0.02) EPS for the quarter. India Globalization Capital had a negative return on equity of 31.15% and a negative net margin of 69.92%. The company had revenue of $0.76 million for the quarter.

COPYRIGHT VIOLATION NOTICE: This news story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/26/india-globalization-capital-inc-igc-short-interest-update.html.

India Globalization Capital Company Profile

India Globalization Capital, Inc engages in the development of cannabis-based therapies to treat Alzheimer's, pain, nausea, eating disorders, several end points of Parkinson's, and epilepsy in humans, dogs, and cats. The company's products under medical trials include Natrinol, a natural substitute for Marinol for relieving nausea, vomiting, and increasing appetite in patients with AIDS and cancer; Caesafin to alleviate seizures in dogs and cats; Serosapse addresses several end points in Parkinson's disease, including Rapid Eye Movement sleep disorder, anxiety, and dyskinesia; and Hyalolex to reduce the buildup of beta-amyloid in Alzheimer's patients.

Receive News & Ratings for India Globalization Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for India Globalization Capital and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply